12:42 PM EST - ProMIS Neurosciences, Inc. : Has identified several novel antibody candidates for Multiple System Atrophy (MSA), a severe, Parkinson's-like disease caused by toxic, misfolded forms of the protein alpha-synuclein. The new antibody candidates join ProMIS' strong pipeline of antibodies that demonstrate high selectivity for toxic misfolded proteins, implicated as a root cause of several neurodegenerative diseases, including Alzheimer's, Parkinson's and amyotrophic lateral sclerosis. ProMIS Neurosciences, Inc.
shares T.PMN are trading down $0.005 at $0.22.